Conference Agenda

11:00am - 11:24am

Exploiting NMR to extract pharmaceutically relevant properties of small molecules

LaPlante, Steven

NMX Research and Solutions, Inc., Canada

11:24am - 11:48am

Structure-based "First-in-class" drug development: Application to Acute Myeloid Leukemia and Pterygium

Yang, Min Jun¹; Lee, Donghan¹; Song, Ji-Joon²; Lee, Weontae^3,4

1: KBSI, Ochang-Eup, Republic of Korea; 2: KAIST, Daejon, Republic of Korea; 3: Yonsei University, Seoul, Republic of Korea; 4: Epinogen, Daejon, Republic of Korea

11:48am - 12:12pm

NMR in the era of diverse pharmaceutical modalities

Takeuchi, Koh

The University of Tokyo, Japan

12:12pm - 12:24pm

19F NMR for drug discovery: design and validation of the OpenFL600 screening library and titration-free KD determination based on 19F CSA relaxation

Rüdisser, Simon; Stadler, Gabriela; Padroni, Giacomo; Gossert, Alvar

ETH Zürich, Switzerland

12:24pm - 12:36pm

Advancing high sensitivity biomolecular NMR through spin polarization and specific stable isotope labeling

Miyanoiri, Yohei^1,2; Takeda, Mitsuhiro³; Okuma, Kosuke⁴; Kodama, Takashi¹; Ikenoue, Tatsuya¹; Inomata, Kohsuke²

1: Institute for Protein Research, The University of Osaka, Japan; 2: Core for Spin Life Sciences, Okazaki Collaborative Platform; 3: School of Pharmacy, Tokyo University of Pharmacy and Life Sciences; 4: SAIL Technologies Inc.

12:36pm - 1:00pm

NMR: A versatile toolbox for protein/ligand discovery

Gardner, Kevin^1,2,3; Gagné, Donald¹; Azad, Roksana¹; Xu, Xingian¹; Closson, Joseph¹; Boral, Soumendu¹; Rizwan, Fatima¹; Favaro, Denize¹; Aramini, James¹; Johnson, Bruce¹; Sharma, Diksha⁴; Partch, Carrie^4,5

1: CUNY Advanced Science Research Center, United States of America; 2: City College of New York, United States of America; 3: CUNY Graduate Center, United States of America; 4: UC Santa Cruz, United States of America; 5: Howard Hughes Medical Institute, United States of America